New vaccine trials, deciding who gets vaccines first, a look back at 2020, federal funding package and much more

View this in your browser.


December 28, 2020


Photo by Kevin Grieve on Unsplash

Dear Friends and Neighbors,

I hope all of you who have been celebrating the holidays were able to enjoy some respite from the pandemic and being in touch, albeit mainly remotely, with family and friends, and that we’ll all be able to celebrate in a more “normal” way next year.

Today we’re focusing on the latest vaccine news and taking a look back at this most significant and challenging (mostly horrible) year.  The pandemic continues to have broad impacts (both positive and negative) throughout society - - certainly on our health and work lives, but also on our education systems, housing, the arts, activism and the environment.

While we are all looking forward to the end of 2020 and hopefully to widespread vaccinations in 2021, we must remain determined to beat back the virus this winter.  We are looking at some rough months ahead, especially with the new – and apparently more transmissible – variants that are spreading.  Keep wearing your masks, staying physically distant, and washing your hands often. 

This week we will send out a shortened version of the e-newsletter on Thursday, New Year’s Eve. 

As always, I would like to hear from you. You can call me at 206-477-1004 or you can reach me by email at 

All the best and I hope you are staying safe.